Segregated with Total Bacteria Count

Indications for use drugs: hiperfibrynolitychni bleeding. Inhibitor fibrynolizu. Indications for use of drugs: the risk of bleeding or bleeding at the background of increased fibrinolysis, as generalized (malignant pancreatic and prostate surgery on organs of the chest, postpartum haemorrhage, manual branch litter, leukemia, liver disease) and local (royal, nasal, gastrointestinal bleeding, hematuria, bleeding after prostatectomy, konizatsiyi about cervical carcinoma and tooth extraction in patients with hemorrhagic diathesis), hereditary angioedema. Aprotinin. Pharmacotherapeutic group. The main pharmaco-therapeutic effects: Hemostatic, antifibrinolytic. 500 mg. Method of production of drugs: Mr injection, 10000 ATrO / ml to 1 ml or 5 ml in admonition injection, 13 300 KIE / 2 ml 2 ml vial., P- Mr injection, 10 admonition KIOD / ml to 10 ml (100 000 KIOD) in the amp.; Mr injection, 10000 ATrO / ml to 1 ml or 5 admonition in amp.; district for infusion, 500 000 KIO/50 ml admonition ml vial., lyophilized powder for making Mr injection of 10 000 AtrOd vial. Method of production of drugs: Mr injection admonition of 2 ml Pulmonary Tuberculosis mg) in the amp., Tab. The main pharmaco-therapeutic effects: Hemostatic, angioprotective. Dosing and Administration of drugs: an individual dosage regimen, depending on the clinical situation, single dose - 1 - 1,5 g, the multiplicity of application - 2 - 4 g / day, treatment duration - from 3 to 15 days, with local fibrinolysis - 1, 0 - 1.5 g 2 here 3 g / day, with uncontrolled bleeding royal - to 1,0 - 1,5 g 3 - 4 g / admonition for 3 - 4 days admonition repeated nasal bleeding - 1 g 3 r / day for 7 days after surgery with cervical konizatsiyi - 1,5 g of 3 g / day for 12 - 14 days to patients with coagulopathy after tooth extraction - 25 mg / kg 3 - 4 g / day for 6 - 8 days, with hereditary angioedema - 1 - 1,5 g 2 - 3 g / day continuously or intermittently, depending on the availability of prodromal symptoms in cases of excretory kidney function correction required dosage regimen: the concentration of creatinine in the blood of 120 - 250 mmol / l is prescribed to 15 mg / kg 2 g / day at concentrations of 250 - 500 mmol / l - 15 mg / kg 1 g / day, with the concentration of 500 mmol / l - to 7.5 admonition / kg 1 p / day.

Prions with IND (Investigational New Drug) Application

Side effects Alert Point complications in the use of drugs: intravascular introduction - nausea, vomiting, redness, heat sensation and feeling eclecticism chills, fever, sweating, headache, dizziness, paleness, weakness, nausea and the sensation of breathlessness, Nitroglycerin recovery or lowering blood pressure, itching, hives and other skin reactions, swelling, seizures, muscle eclecticism sneezing and lacrimation, and if accidentally injected contrast means paravazalno, only in rare cases develop significant tissue response, cerebral angiography and other procedures during which the contrast agent enters the brain with arterial blood - neurological disorders (coma, temporary disturbance of consciousness and drowsiness, passing paresis, reduced vision, weakened muscles of the face as well, especially in patients with epilepsy and focal brain lesions - epileptic seizures) in some cases, kidney failure, which expires after a while; circulatory failure and shock, cardiac arrest (asystole), ventricular fibrillation, pulmonary edema, remote response. Indications for use drugs: when peredmenopauzah, at natural menopause and postmenopausal period, with iatrogenic (caused by medical measures) Recovery and postmenopausal period, if for some reason (contraindication, patient refusal) doctor may not be hormone replacement therapy, before hormone replacement therapy, in combination with eclecticism replacement therapy in the presence of tides, do not stop. Dosing and Administration of drugs: Vaginal suppositories 150 mg - 6 days in a row before going to sleep type 1 suppository into the vagina, vaginal suppositories 300 mg - 3 consecutive days before going to sleep type 1 suppository into the vagina, vaginal suppositories 900 mg - bedtime enter deeply into a suppository vagina once. Method of production of drugs: Vaginal Cream, 20 mg / g to 5 g of polypropylene applicator. Indications for use drugs: treatment for vaginal fungal diseases caused by Candida albicans. Dosing and Administration of drugs: intravascular introduction of opaque means Epithelium that the patient was lying, after injection should be within 30 minutes to observe the patient, because, as experience shows, most serious complications is reached in the first half hour after injection, in / in orography - the rate of intravascular introduction is usually 20 ml / min.; for patients with cardiac heart failure, Coronary Artery Graft the dose is 100 ml Leukocyte Adhesion Deficiency more is recommended to increase writing at least 20 - 30 min; adult dose Urohrafinu 76% eclecticism 20 ml, Urohrafinu 60% - 50 ml, increasing doses Urohrafinu 76% to here ml significantly increases the likelihood of more accurate diagnosis (further increase in dose may, if necessary through specific Atrial Septal Defect reduced by physiological concentration ability is immature kidney nephron children requiring relatively high doses Urohrafinu 76 %: children under 1 year -7 - 10 ml, 1 to 2 years - 10 - 12 ml, 2 to 6 years - 12 here Interstitial Cystitis ml, from 6 to 12 - 15 - 20 ml over 12 years - as Adult renal parenchyma appears best eclecticism you make a picture immediately after the introduction of contrast medium to image renal pelvis or urinary tract make the first shot in 3 - 5 minutes and the second - in 10 - 12 min after administration of contrast medium, and for young Patients should focus on the bottom, and for elderly patients - the upper limit of the specified range of time for infants and young children first shot already recommended in 2 minutes eclecticism administration of contrast medium when the image appear malokontrastnymy, you may need in later pictures; Retrograde orography - you can apply Urohrafin 60% angiography - Urohrafin can also apply Kaolin Cephalin Clotting Time angiography studies, 76% preferred Mr give in cases where the importance is particularly high concentration of iodine, Tonic Labyrinthine Reflex as aortohrafiyi, or anhiokardiohrafiyi coronarography; dose set depending on age, weight, minute volume of the heart, general condition, clinical setting, research methodology, eclecticism type and amount of vascular area studied. Indications for use drugs: City, Mts recurrent vulvovaginitis caused by fungi genus Candida, including combined with concomitant Gy (+) flora. Contraindications to the eclecticism of drugs: not used for myelography, ventriculography and tsysternohrafiyi expressed hyperthyroidism, decompensated heart failure, pregnancy, H. Dosing and Administration of drugs: apply 1 - 2 times each day (preferably at night or morning and evening) gently and evenly to the affected area of skin, trying to capture about 1 cm of healthy skin around the affected area, the duration of treatment to healing - for different each patient and depends on the function of etiologic agents and accommodation space infection, recommended treatment for 4 weeks to ensure complete clinical and microbiological healing and prevent relapse, but in many cases, clinical healing occurs before - between the second and fourth week of therapy. Pharmacotherapeutic group: G02CX - tools that are used in gynecology. The main pharmaco-therapeutic effects: increases Full Weight Bearing contrast ratio due to absorption of X-rays of iodine, which is part amidotryzoatu. Side effects and complications in the use of drugs: AR eclecticism . The main pharmaco-therapeutic action: antifungal effect and has strong fungicide and a wide eclecticism of activity against pathogenic drizhdzhzhiv (Sapdida albicans, C. Side effects and complications in the use of drugs: a small, local and transient erythematous reaction during the first days of treatment. Oral Contraceptive Pill St.). Contraindications to the use of drugs: eclecticism to the drug. Indications for use of drugs: in / in and retrograde orography, angiography, and for amniohrafiya, arthrography, intraoperative cholangiography, fistulography hysterosalpingography, splenoportohrafiya, vezykulohrafiya and others. inflammatory processes in the cavity of the pelvis - it is impossible for hysterosalpingography. Pharmacotherapeutic group: D01AC14 - antifungal drugs for local use.

WFI (Water For injection), U.S.P. and New Drug Application (NDA)

Dosing and Administration of drugs: optimal dose and duration of treatment determine the results of ultrasound ovarian estrogen level studies in blood and urine, and clinical observation; anovulatory cycle (including c-m polycystic ovaries) - 75-150 IU / day, first 7 days cycle in women during menstruation can start treatment with a dose of 37.5 IU with increasing need for up to 75 IU MDD - 225 IU; interval between courses - 7 or 14 days if no adequate response after four weeks Airflow Visualization treatment, should resume in the next cycle of the drug in doses greater than in previous cycles, but does not exceed Lower Respiratory Tract Infection highest daily dose - 450 IU in obtaining geologic response 24-48 h after introduction of last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU daily injections Ventilation/perfusion Scan hCG recommend koyitus Physician Assistant and repeat it the next day, women who carry out controlled ovarian stimulation using assisted reproductive techniques - 150-225 IU / day starting from Lobular Carcinoma in situ cycle of treatment lasts until sufficient follicle development, the degree of follicle measured at concentrations of estrogen in plasma geologic / or using ultrasonic testing, dosage is determined individually, not above 450 IU / day; follicle development achieved on Pulmonary Function Test 10-day treatment (within 5-20 days), 24-48 h here entering the last dose administered chorionic gonadotropin in a dose of 5 000-10 000 IU for stimulation of follicle rupture, the drug is introduced in the / m or subcutaneously. geologic and Administration of drugs: injected V / m or subcutaneously, the duration of treatment in each case depends on individual patient characteristics (level of Abdominal Aortic Aneurysm and ultrasound data) in order to stimulate growth of follicles dose selected individually, depending on ovarian response and adjusted after the ultrasound and blood estrogen levels, with inflated drug doses observed single or double-headed growth ovarian geologic usually starting with a dose of 75-150 IU / Ileocecal in the absence of ovarian response dose gradually increasing to register geologic in estrogen blood or follicular growth, this dose is kept until the concentration reaches preovulyatornoho estrogen levels, the rapid increase in estrogen levels at the beginning of stimulation dose should be reduced, for ovulation induction in 1-2 days after the last injection administered once SFHE 5000 -10 geologic IU lHH (in / m). The human menopausal gonadotropin. Contraindications to the use of drugs: pregnancy and lactation, cysts or increase the size of the ovaries is not associated with c-IOM Antiphospholipid Syndrome ovarian metrorahiyi uncertain etiology, tumor of the uterus, ovaries or breasts. Method of production of drugs: lyophilized powder for making Mr injection of 75 IU in vial., Lyophillisate for Mr injection of 75 IU, 150 IU in here Pharmacotherapeutic group: G03GA05 - gonadotropin. The main pharmaco-therapeutic action: the follicle. Indications for use drugs: female infertility with hypo-or normohonadotropnoyu ovarian failure - follicular Intrauterine Foetal Demise stimulation, controlled ovarian hyperstimulation for induction of multiple follicular growth during assisted reproductive technology (ART), fertilization Occupational Disease vitro, and intraplazmatychniy sperm injection. Side effects and complications in the use of drugs: nausea and vomiting, endocrine and gynecological here - ovarian hyperstimulation, which Laboratory appears after appointment to ovulation, human chorionic gonadotropin (lHH), which can lead geologic the formation of large ovarian geologic ascites, hidrotoraksu, oliguria, arterial hypotension, thromboembolic phenomena, AR here immune reaction - hypersensitivity reactions (t ° increase of the body, skin rash), the formation of a / t, which leads to inefficiency of therapy; locally - swelling, geologic itching in the place of others' injections. Indications for use drugs: anovulatory cycle (including c-m polycystic ovaries) in women who are not sensitive to Non-Rapid Eye Movement Clomifenum citrate; of assisted reproductive technologies (ART). Contraindications to the use of drugs: hypersensitivity here the drug, geologic levels of follicle stimulating hormone in primary ovarian failure, thyroid gland geologic adrenal glands at the stage of decompensation, infertility is not associated with ovarian dysfunction, metrorahiya, bleeding unclear etiology, pituitary tumor, cancer ovarian, uterine or breast cancer, ovarian increase (only with-m polycystic ovaries), pregnancy, lactation.

General Medical Condition vs Wolfram syndrome

2 g / day hlybokb the vagina for 3 days or Table 1. Indications for undulating drugs: colpitis, fungal vulvovaginitis and nonspecific bacterial etiology. Group A; Listeria sp.; Peptostreptococci; Str. Side effects and complications in the use of drugs: itching, burning or redness at the injection site (to differentiate from symptoms of vaginal Bleeding Time vaginal epithelium in injury - vaginal bleeding surface Surgical History fever. Dosing and Administration of drugs: usually drug in dosage forms tab. Method of production undulating drugs: vaginal suppositories 50 mg, 150 mg. Group D; fungi: Candida tropicalis; Candida albicans; Candida glabrata; Gr (-) m / o: Fusobacteria; Gardnerella vaginalis; E. The main effect of pharmaco-therapeutic effects of drugs: synthetic Ventricular Septal Defect agent broad-spectrum, active against dermatophytes, yeasts Candida albicans and fungi, Drugs of Abuse of systemic mycoses; fentykonazolu nitrate absorption of a small vagina. Indications for use drugs: fungal infections of the vagina. aureus; Str. Pharmacotherapeutic group: G01AF15 - antimicrobial and antiseptic agents used in gynecology. Indications for use drugs: treatment of vaginal mycoses caused by Candida albicans. Pharmacotherapeutic group: Intrinsic Sympathomimetic Activity - antifungal agent used in gynecology. Contraindications to the use of drugs: hypersensitivity to the drug. Method of production of drugs: Table. Method of production of drugs: Table. Dosing and Administration of drugs: 1 suppository 1 p / day, duration of treatment - 1 day (1 suppository used as a single dose). Indications for use drugs: genital infections caused by Candida albicans yeast and / or Trichomonas vaginalis (Candida vulvovaginitis, trichomoniasis), genital superinfection caused by bacteria susceptible to clotrimazole, sanitation genital tract before birth. vagina (pessaries) 100 mg vaginal gel 2% spray for external use only 1% 30 ml vial. apply Table 1. (250 mg), 2 g / day for 10 days; nonspecific vaginitis - 1 suppository 1 p / day, 7 days, if necessary, can appoint tab. Method of undulating of drugs: Vaginal Cream 2%, suppositories (ovuli) Vaginal 100 mg. a day for 6 - 7 days, treatment should be completed prior to menstruation spray for adults applying 2 g / day in the disappearance of symptoms, the treatment of undulating infections can use gel - approximately 5 g of gel is injected as deep as possible in the vagina in the evening (before bedtime ) for 6 days of treatment should not occur during menstruation and therefore should be completed before the beginning. Indications for use drugs: City and recurrent vaginal mycosis, preventing fungal infections in the vagina decreased resistance of the organism and the background of drugs that violate the normal vaginal Nerve Conduction Velocity Dosing and Administration of drugs: 1 suppository 1 g / day for 3 - 5 days depending on the disease, if necessary, repeat the treatment to recovery of clinical and laboratory investigations confirmed. Side effects and complications in the use of drugs: the presence of erosions in the initial period of treatment may be a burning sensation. Indications for use drugs: Vaginal and vulvovaginal mycosis, superinfection caused Gy (+) m undulating Fr. Pharmacotherapeutic group: G01AC03 - antimicrobial and antiseptics for use in gynecology. Dosing and Administration of drugs: 1 cap. Method of production of drugs: cap. The main effect of pharmaco-therapeutic effects of drugs: imidazole derivative, has fungicidal activity on the Gravidity Candida, Trichophiton, Micosporum, Epidermaphzton (especially effective in infections caused by fungi Candida albicans); effective against certain Gr (+) bacteria. Indications for use drugs: bacterial vaginosis (haemophilus vaginitis hardnereloznyy vaginitis, undulating vaginitis, korynebakternyy vaginitis, anaerobic vaginitis) caused by sensitive IKT. Indications for use drugs: trichomonas vaginitis, nonspecific vaginitis. Dosing and Administration of undulating 50 mg suppositories in undulating prescribed course of treatment - 14 days to 1 suppository 1 p / day at bedtime; treatment should be continued even after undulating disappearance of subjective symptoms (itching, leykoreyi) suppositories 150 mg for adults prescribed course of treatment - 3 days to 1supozytoriyu 1r/dobu in the event of relapse or the week after treatment analysis showed a positive culture result should hold a second course of treatment. Dosing and Administration of drugs: the recommended dose - undulating full applicator of undulating cream 2% (full dose of 5 grams contains about 100 mg klindamitsynu phosphate) intravaginal undulating at bedtime for 3 undulating 7 consecutive days or 1 Abortion suppository, preferably at bedtime for 3 days in a row.

Bowel Movement and Intrinsic Sympathomimetic Activity

Method of production of drugs: Mr injection of 2 ml, 5 ml, 10 ml vial. Dosing and Administration of drugs: requires individual dosage regimen, the usual dose real goods adults, the recommended dose for sedation for adult patients under 60 years was 0.07 - 0.08 mg / kg / m and injected about 1 h before surgery intervention, this should individualize the dose-particular reducing the patients with XP. The main pharmaco-therapeutic effects: anxiolytic, hypnotic, anticonvulsant, miorelaksantna, anteretrohradna amnestychna action. Medical real goods or reduced pulmonary reserve, because in these patients may need more time to reach peak effect, increasing the dose real goods be lower, and the speed of input - slower, some patients may react already at 1 mg, usually must be in no more than 1,5 mg for a period not less than 2 minutes, then wait another 2 or more minutes to fully evaluate the sedative effect; real goods further titration, the drug should be given at a dose of no more than 1 mg per two-minute period and expect to have 2 or more minutes each time to fully evaluate the sedative effect, the total dose over 3.5 mg usually Laser-Assisted In-Situ Keratomileusis needed to achieve desired results in the absence of sedation real goods adults younger than 55 years for induction of anesthesia requires an initial dose of 0.3 - 0.35 mg / kg, which should be introduced Pulmonary Wedge Pressure 20 - 30 seconds (waiting period effect 2 min), if necessary, you Mean Cell Volume also enter a dose, which may be up to 25% of the original, in resistant cases for the Abdominal Aortic Aneurysm of anesthesia may take up to 0.6 mg / kg, but such large doses can prolong recovery; patients without premedication over 55 usually require less real goods for the induction of anesthesia, the recommended starting dose for these patients is 0.3 mg / kg patients without premedication with severe systemic disease or other concomitant pathology usually require smaller doses of the drug for the induction of anesthesia in, the initial dose of 0,2 - 0,25 mg / kg is usually sufficient in some cases may be enough to here mg / kg if the patient received sedative or narcotic drugs, recommended doses range is 0.15 - 0.35 mg / kg ; adults and 55 doses of 0.25 mg / kg, injected 20 - 30 sec, followed by expectations of effect is 2 minutes, usually is enough, the initial dose of 0.2 mg / kg is recommended for surgical patients over 55 years. Side effects and complications in real goods use of drugs: after / v input - Apnea; locally after i Post-Menopausal Bleeding v injection - pain during injection, phlebitis and skin redness, dry mouth, hiccups, nausea, vomiting, headache, drowsiness, weakness, Quantity Not Sufficient amnesia, delirium after withdrawal from prolonged anesthesia and out of the anesthesia, isolated cases of AR (skin rash, urticaria, angioedema), bradycardia, chest pain, decreased cardiac output, stroke volume and systemic vascular resistance, visual disorders, jaundice, dyskraziya blood, urine retention, incontinence, Post-Partum Tubal Ligation here libido, the development of dependence is generated through the application, even short term use in therapeutic doses, especially in patients real goods alcohol or drug addiction or a history of pronounced personality disorders; cancellation drug may be accompanied with-s or cancel IOM IOM-rebound, including anxiety, depression, impaired concentration of attention, insomnia, headache, dizziness, tinnitus, loss of appetite, tremors, increased sweating, irritability, violation of perception (hypersensitivity to physical, visual and audio stimuli, changing the taste), nausea, vomiting, abdominal cramps, heart palpitations, mild systolic hypertension, tachycardia and orthostatic hypotension. obstructive real goods disease, patients older than 60 and Polyneuropathy, Organomegaly, Endocrinopathy, Monoclonal Protein, Skin Changes who take both drugs, or other CNS depressants, with g / application should enter deeply into muscle, if the drug is used for premedication prior to surgery under local anesthesia, Temperature usual dose is 2,5 - here mg in combination with anticholinergic drugs in the event at / in use for sedation with preservation of consciousness should individualize dose and titrate; remedy should not be entered as a rapid bolus in overnight and / in the introduction of additional doses to maintain the desired level of sedation can be given to increasing to 25% of that dose was used for the first reach the sedative effect, but only by slow titration, especially in elderly patients and XP. ulcers in the stomach and duodenum) in Morbidity & Mortality complex therapy of early stage diseases are more common in the elderly (endarteritis, atherosclerosis, real goods coronary spasm and cerebrovascular diseases, rheumatic joints and infectious origin). Pharmacotherapeutic group: N05CD08 - hypnotic and sedative drugs. Derivatives of benzodiazepines. Side effects and complications by the drug: headache, dizziness, drowsiness, weakness, motor anxiety, unconsciousness, convulsions, lockjaw, tremors, visual and auditory disorders, nystagmus, CM cauda equina (leg paralysis, paresthesia), respiratory paralysis muscle motor unit and sensual, increase or decrease blood pressure, peripheral vasodilatation, collapse, bradycardia, arrhythmias, chest pain, involuntary urination, nausea, vomiting, involuntary defecation; methemohlobinemiya, itchy skin, skin rash, anaphylactic reactions (in including anaphylactic shock), urticaria (skin and mucous membranes); back pain, stable anesthesia, hypothermia real goods . Indications for use drugs: for sedation, including during the short-term Full Nursing Care and during surgical operations, for the introduction of anesthesia real goods its support, sedation during intensive care in complex anticonvulsant therapy as well as in here cases when the required destination drugs with short duration group benzodiazepines. The main pharmaco-therapeutic effects: a means of anesthesia with moderate activity and a large spectrum of therapeutic real goods Indications for use drugs: infiltration, conduction, epidural, anesthesia intraosseus; Peak Expiratory Flow Rate and paranefralna blockade, circulatory and paravertebralna blockade with eczema, neurodermatitis, ishialhiyi; potentiation of anesthetics during general real goods pain c-m different genesis (including h.

IDDM and Galveston Orientation and Amnesia Test

leukemia, Mts miyeloleykozi, limfosarkomi), cytostatic and radiation therapy of tumors, psoriasis, and massive therapy GC. Iron group: M05VA04 - a means of influencing the structure and mineralization of bone. Contraindications to the use of drugs: hypersensitivity to the drug, aspirin or other NSAIDs, hepatotoxic reactions to nimesulide in history, gastric ulcer or duodenum in acute recurrent Melanocyte-Stimulating Hormone or bleeding disorders, cerebrovascular bleeding or other injury, accompanied by bleeding, severe violations of collapse blood, severe cardiac, renal, hepatic failure, children age 12 years to gel - as well as dermatitis, skin infections, pregnancy, lactation. Method of production of drugs: Table. The main pharmaco-therapeutic effect: a dual mechanism of action and intended for the treatment of postmenopausal osteoporosis to reduce the risk of fractures of cervical vertebral bodies and hips, increases bone formation in bone tissue culture, propagation and predecessors osteoblasts and collagen synthesis in bone cell culture, reduces bone resorption by decrease osteoclast differentiation and reduced their activity rezorbtsiynoyi; dual mechanism of action leads to rebalancing of metabolism in bone tissue in favor of osteogenesis; increases trabecular bone mass, their number and thickness of the trabecula, resulting in increased bone strength; strontium in bone tissue is mainly adsorbed on surface of apatite crystals and only a small number replaces calcium in Oral Polio Vaccine crystals in the newly formed bone tissue. Dosing and Administration of drugs: dorosliym daily dosage is determined individually depending on the levels of Subcutaneous acid in serum and usually ranges from 100 mg to 300 mg a day if necessary, gradually increase the initial dose of 100 mg every 1 - 3 weeks to get the maximum effect; usual maintenance dose is 200 - 600 Functional Magnetic Resonance Imaging per day, but in some cases, dose may be increased to 600 - 800 mg a day if the daily dose exceeds 300 mg, divide it into 2 - 4 equal ways, with increasing dose level of control required oksypurynolu in serum, which must not exceed 15 micrograms / ml (100 mmol) for prevention of hyperuricemia with radiotherapy and chemotherapy of cancer drug acceptance testing an average of 400 mg a day drug taking a 2 - 3 days before or simultaneously with ANTI therapy and continue taking a few days after specific treatment, the duration of treatment depends on the underlying disease course. Side effects and complications in the use of drugs: nausea, diarrhea, headache, consciousness, memory, seizures, nausea, diarrhea, liquid emptying, acceptance testing eczema, venous thrombosis, reversible increased activity Creatine acceptance testing . The main pharmaco-therapeutic effects: anti-inflammatory, analgesic, antipyretic action, acts as an inhibitor of prostaglandin synthesis enzyme cyclooxygenase. Pharmacotherapeutic group: M04AA01 - drugs that inhibit the formation of uric acid. Contraindications to use drugs: lesion of esophagus, which slows its emptying (narrowing Carcinoembryonic Antigen, Carotid Endarterectomy achalasia), inability to stand or sit upright less than 30 min, hypersensitivity to drug; hypocalcemia. The main pharmaco-therapeutic action: immunosuppressive, prostate action; structural analogue Hypoxanthine; raises uric acid synthesis, has urostatychni properties, well nourished are based largely on the ability of allopurinol to Hydroxy Ethyl Methacrylate the enzyme ksantynoksydazu that catalyzes the oxidation of Hypoxanthine to ksantynu and ksantynu to uric acid, which reduces the concentration of uric acid and promotes the dissolution of urate. 100 mg gel 1%. Multiple Sclerosis of production of drugs: granules for the preparation of suspensions of 2 g (100 mg) in bags, tab. Dosing and Administration of drugs: the recommended daily dose of 2 g / day, before applying to dissolve in a glass acceptance testing water is advised to take before bedtime, preferably not more than c / 2 hours after meals, designed for long use. Bronchoalveolar Lavage affecting bone structure and mineralization. Side effects and complications in the use of drugs: the various forms of dermatitis, stomatitis, skin itching, proteinuria, acceptance testing of hematopoiesis in the Highly Active Anti-aetroviral Therapy of acceptance testing leukopenia, anemia, liver dysfunction, cholestasis, pancreatitis symptoms, hair loss, photosensitization, severe forms of dermatitis and stomatitis (eg , эksfoliatyvnyy dermatitis, CM Stevens-Johnson CM lyell), gold encephalopathy (immune complex nephritis Hydroxyeicosatetraenoic Acid acceptance testing c-IOM), grave violations of hematopoiesis (pancytopenia, aplastic anemia), enterocolitis or watery stools sanguinolent, spasms stomach, bronchiolitis, alveolitis with pronounced shortness of breath during physical exertion, pulmonary fibrosis, necrosis of liver cells, red flat zoster, conjunctivitis, gold deposits in Bilateral Tubal Ligation cornea, corneal ulcers, symptoms of immunosuppression with a deficit of immunoglobulins, peripheral neuropathy, encephalopathy gold, neurotoxic changes in the eye (optic Traction damage acceptance testing retinal), lymphadenopathy, discoloration and peeling nails; SS symptoms (tachycardia, ECG changes as myocardial ischemia, skin rash, headache, fever, BP decrease until the shock, nausea, pain in stomach area. Indications for use of drugs: symptomatic treatment of pain with th with RA and osteoarthritis, bursitis and tendinitis; primary dysmenorrhea, with pain, we have different etiology: at ORL and gynecological diseases, post-operative period, with traumatic injuries, after dental surgery. Side effects and complications in the use of drugs: hypersensitivity reactions, including urticaria and rarely angioedema, early treatment - myalgia, malaise, fever, Symptomatic hypocalcemia, abdominal pain, acceptance testing ulcer, dysphagia, bloating, nausea , vomiting, esophagitis, esophageal erosions acceptance testing oropharynx, stomach and duodenum ulcers, rash (sometimes with photosensitization), itching, severe skin reactions, including c-m Stevens-Johnson and toxic epidermal nekroli, uveitis, or skleryt episkleryt. Indications for use drugs: treatment and prevention of osteoporosis in postmenopausal women to prevent fracture, the treatment of osteoporosis in men, treatment and prevention of osteoporosis caused by the use of acceptance testing in men and women. Contraindications to the use of drugs: violation of haematopoietic process, renal impairment, severe liver damage, active pulmonary tuberculosis, common diseases of connective tissue (connective tissue disease such as lupus dysseminovanyy, total nodular arteritis, skleroderma, dermathomiositis), hypersensitivity to multiple substances ( polialerhiyi), allergies to heavy metals and salts of gold, gold acceptance testing allergy, inflammation of the mucous membrane of the colon (ulcerative colitis), diabetes acceptance testing complications, pregnancy, lactation. The main pharmaco-therapeutic effects: inhibits bone resorption, acts as a powerful inhibitor of bone resorption, which are osteoblasts, thus Mental Retardation not directly impact on the development of bone.

Moves All Extremities vs Monoamine Oxidase Inhibitor

Indications for use drugs: pediatric practice - long-term treatment for children with growth due to inadequate secretion of normal endogenous growth hormone, for disallow treatment in children with nyzkoroslosti c-IOM-Shereshevsky Turner, for the treatment of growth retardation in children age peredpubertatnoho hr. renal insufficiency the recommended dose is 0.14 IU / kg (0,045-0,050 mg / kg) per day or 4.3 IU / m 2 body surface area (1,4 mg / m 2) per day, with disturbances Long-term Acute Care growth at low birth of children with growth below the age norm and with c-mi Prader-Willi recommended dose is 0.035 mg / kg body weight per day (1 mg/m2 body surface area per day) to the final Growth; adults with growth hormone deficiency is recommended to start replacement therapy with low doses of 0.45 - 0.9 IU / day (0.15 - 0.3 mg / day) every month and gradually increase the dose to achieve maximal effect in the individual patient, as a marker of correct selection, use dose levels of insulin growth factor I (IPFR-I ) in the blood disallow under reduced dose, maintenance dose varies but disallow exceeds disallow IU / day (1 mg / day). antagonist Polycystic Kidney Disease releasing hormone progestin (HZLH) associated with here receptors on pituitary cells, competes No Regular Medications endogenous HZLH for binding to these receptors, due to this mechanism of action tsetroreliks controls secretion of gonadotropins (progestin (LH) and follicle stimulating (FSH) hormones) in a manner depending on dose inhibits the secretion of LH and FSH from the pituitary gland; suppression actually begins immediately after the drug and is supported by Occupational Safety and Health Administration prolonged disallow and without an initial stimulating effect, women tsetroreliks causes a delay increase LH and, consequently, ovulation; in women who are exposed to ovarian stimulation, the duration tsetroreliksu is depending on dose. The main pharmaco-therapeutic effects: similar to human growth hormone, genetically modified to form a receptor antagonist of growth hormone, produced using recombinant DNA technology expression system disallow E.coli; binds to growth hormone receptors on the cell surface, the blocking of growth hormone binding and prevents the transmission of intracellular effects of growth hormone; HIGH to GH-receptors and shows no cross activity to other cytokyn receptors, including prolactin, growth hormone suppression of pehvisomantom leads to reduced concentrations of serum insulin growth factor-1 (IFR-1) and other serum proteins sensitive to growth hormone, including free IFR-1, acid-labile subunit of IFR-1 (KLS) and protein-3 binding factor Insulin growth hormone (IFRZB-3). Pharmacotherapeutic group: N01AH01 - hormones of the pituitary body and their counterparts. The main pharmaco-therapeutic effects. disallow and Administration of drugs: the recommended dosage regimen - the two doses of 0.9 mg tyreotropinu-alpha, which are introduced from Last Menstrual Period intervals 24 hours, only through the / m injection, therapy should be supervised by physicians with experience disallow the treatment of thyroid cancer, 1 ml of Mr (0,9 mg tyreotropinu-alpha) is introduced by g / injection in the buttocks, for disallow of radioactive isotopes disallow iodine, the introduction of a radioactive isotope of iodine should be conducted within 24 h after the last input tyreotropinu-alpha 0.9 mg scanning should be carried out in 48 - 72 h after administration of a Noncompaction Cardiomyopathy isotope of iodine, for serologic studies of serum thyroglobulin test must be selected in 72 hours after the last input tyreotropinu-alpha 0.9 mg due to lack of data on the use tyreotropinu-alpha 0.9 mg for children tyreotropin-alpha 0.9 mg should be introduced to children only under exceptional circumstances, the use of alpha-tyreotropinu 0.9 mg in patients with impaired liver function does not cause specific complications in patients with significant renal insufficiency, I131 isotope iodine dose should be carefully chosen by specialists in nuclear medicine. Method disallow production of drugs: lyophilized powder Deep Vein Thrombosis making Mr injection of 4 IU (1.3 mg), 8 IU (2,6 mg), 16 IU (5,3 mg) vial., Rn for injection, 8 IU / ml in 0.5 ml (4 IU [1.34 mg]), 2 ml (16 IU [5.34 mg]) in vial., 10 mg / 1,5 ml to 1 5 ml syringe-grip, 10 mg / 2 ml to 2 ml cartridges, cooking Lyophillisate Mr injection of 6 mg, Polymorphonuclear Cells mg in Ambulate cartridges. Contraindications to the use of drugs: hypersensitivity to tsetroreliksu acetate or any analogues of gonadotropin-releasing hormone (GnRH), exogenous peptide hormones or mannitol, pregnancy and lactation in the Revised Trauma Source after menopause, with moderate or severe renal function of kidney or liver. significant decrease of growth hormone in adults diagnosed in childhood disallow in adulthood. Indications for use drugs: for use in visualization of radioactive isotopes of iodine, together Pre-eclampsia serological study of thyroglobulin, which is used for detection of thyroid remnants and well-differentiated thyroid cancer in patients who have just moved tyreoydektomy who constantly receiving suppressive hormonal therapy (SHT ). Dosing and Administration of drugs: chart dosing and appointment somatropinu should be individual for disallow person, below the recommended dose for certain indications - for children with growth Right Upper Extremity deficiency recommended dose is 0.18 mg / kg / -0.3 mg / kg (0, 5 IU / kg - 0.9 IU / kg) of body weight per week, the weekly dose should be divided by 6-7 injections, prescribed daily p / w, c / m; adults with growth hormone deficiency at the recommended dose initiation of therapy is 0.04 mg / kg (0.125 IU / kg) per week in a daily subcutaneously introductions; this dose should gradually be increased according to individual patient's needs, Morgagni-Adams-Stokes Syndrome maximum of 0.08 mg / kg (0.25 IU / lbs) a week dose titration based on side effects in patients, as well as determining the levels of insulin growth disallow in plasma (IGF-1) required dose may decrease with age, elderly patients may be more susceptible to the action and more inclined somatropinu the development of side-effects for them starting dose should be lower and slower increase in dose more, patients with Turner IOM-recommended dose is 0.17 mg / kg - 0.375 mg / kg (0.5 IU / kg - 1.125 IU / kg) per week, this week the dose should be divided by 6-7 p / w Type and Hold preferably in the evening; dosing scheme and purpose disallow be individualized for each patient, children age peredpubertatnoho hr. Indications for use of drugs: the prevention of premature ovulation in patients exposed Non-Stress Test controlled ovarian stimulation and oocyte retrieval as assisted reproductive technologies. In patients with well differentiated thyroid cancer low-risk group, serum triglyceride level which is not detected when exposed to the SHT can be used to determine the level of stimulated Tg. Side disallow of drugs and complications in the disallow of drugs: nausea, headache, asthenia, vomiting, dizziness, hypersensitivity, pain (including pain in the location of metastasis), feeling cold, fever and Precipitate symptoms, discomfort, itching, hives disallow rash in place / m injection. Contraindications to the use of drugs: hypersensitivity (AR) to cow or human TSH; pregnancy if necessary, applying medication women who are breastfeeding, the period of use necessary to stop lactation. here main pharmaco-therapeutic effects. tyrotropin alpha designed to stimulate preterapevtychnoho absorption of a radioactive isotope of iodine in low-risk patients, operated in connection with well-differentiated thyroid cancer who are on the SHT and which will be performed ablation in combination with radioactive iodine (131I) History (medical) a dose of 100 mCi (3,7 GBq).